Soorena Sadri, DPM
Foot & Ankle Surgery · Fort Myers, FLNPI 1578792339
Payments from drug & device makers
What this record shows
This record is dominated by other: $24,993 of the $28,712 with a category attached, or 87.0%. Skye Orthobiologics LLC accounts for 87.0% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2024 at $25,713 and has fallen 99.9% since, to $24 in 2025. Among foot & ankle surgery clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 43 payments — averaging $667.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Skye Orthobiologics LLC$25K
- Acell, Inc.$2K
- Arthrex$642
- Stryker$548
- Convatec Inc.$179
- Merck$154
- plus $696 from 10 others
What the payments were for
- Consulting fees$1,5005%
- Travel & lodging$5672%
- Food & beverage$1,6516%
- Other$24,99387%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Skye Orthobiologics LLC | 1 | $24,993 |
| Acell, Inc. | 1 | $1,500 |
| Arthrex | 9 | $642 |
| Stryker(2 entities) | 7 | $548 |
| Convatec Inc. | 2 | $179 |
| Merck | 5 | $154 |
| Amgen | 1 | $119 |
| Treace Medical Concepts, Inc. | 2 | $102 |
| Crossroads Extremity Systems, LLC | 1 | $100 |
| Cardiovascular Systems Inc. | 1 | $94 |
| Boston Scientific | 1 | $70 |
| Organogenesis Inc. | 4 | $68 |
| Melinta Therapeutics, LLC | 4 | $67 |
| Smith+Nephew | 2 | $43 |
| KCI USA, Inc. | 1 | $18 |
| Kerecis Limited | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANCHORAGE$279
- InnovaMatrix AC$163
- T2$148
- SIVEXTRO$124
How this compares
$28,712 in reported general payments places this provider in the 90th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 36 | $485 |
| Clindamycin Hcl | 22 | $259 |
| Cephalexin | 32 | $232 |
| Ciprofloxacin Hcl | 20 | $195 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $104 |
| Gabapentin | 13 | $64 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Fort Myers
- Andrew BelisFort Myers$206K
- Chad SimmonsFort Myers$60K
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1M
- Craig BreslauerStuart$971K
- Bradley LammWest Palm Beach$861K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$785K
- Mario CalaHialeah$541K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.